Annual Secretarial Compliance Report for the year ended March 31, 2025.
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services submitted its Annual Secretarial Compliance Report for FY2024-25, prepared by DMK Associates (Practicing Company Secretaries), as required under SEBI LODR Regulation 24A. The Practicing Company Secretary confirmed that the company generally complied with all applicable SEBI regulations, secretarial standards, and listing requirements during the year. One minor non-compliance was flagged: the company delayed the intimation of an investors/analysts meeting scheduled for June 21, 2024 by one working day, notifying BSE and NSE only on June 19, 2024. Both exchanges issued cautionary e-mails on March 28, 2025, advising the company to be more careful in future, but no fine was imposed. The company has no material subsidiaries, no director disqualifications, and no SEBI or stock exchange actions against it.
The compliance lapse is minor and purely procedural with no monetary penalty, and management has confirmed corrective steps to avoid recurrence. This filing is a routine regulatory disclosure and is unlikely to have any meaningful impact on the stock price or shareholder interests.